SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (861)2/4/2002 1:13:53 PM
From: tom pope  Read Replies (1) | Respond to of 2243
 
The ELN typhoon seems to have passed over INCR without a ripple. No trades.
This is from the ELN response posted by Iceberg on the ELN thread

The product under development, for ulcerative colitis, by the business venture is in Phase III clinical testing in 34 medical centres. The product complements Antegren, which is under development for Crohn's disease